Evaluation of tumor necrosis factor-alpha and granulocyte colony-stimulating factor serum levels in lead-exposed smoker workers

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 2, 2007, Pages 239-247

  Di Lorenzo, Luigi ^a,b   Vacca, A ^a   Corfiati, M ^a   Lovreglio, P ^a   Soleo, L ^a  

^a UNIVERSITY OF BARI   (Italy)

^b POLICLINICO   (Italy)

Author keywords

G CSF; Immunotoxicity; Lead; Neutrophils; TNT ; Workers

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; LEAD; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; INDUSTRIAL WORKER; LEAD BLOOD LEVEL; MALE; NEUTROPHIL COUNT; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SMOKING; SMOKING HABIT;

EID: 34547135926     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000204     Document Type: Article

References (40)

1. Singh V.K., K.P. Mishra, R. Rani, V.S. Yadav, S.K. Awasthi and S.K. Garg. 2003. Immunomodulation by lead. Immunol. Res. 28:151.
2. Ewers U., R. Stiller-Winkler and H. Idel. 1982. Serum immunoglobulin, complement C3, and salivary IgA levels in lead workers. Environ. Res. 29:351.
3. Kishikawa H., R. Song and D.A. Lawrence. 1997. Interleukin-12 promotes enhanced resistance to Listeria monocytogenes infection of lead-exposed mice. Toxicol. Appl. Pharmacol. 147:180.
4. Boscolo P., M. Di Gioacchino, E. Sabbioni, F. Benvenuti, P. Conti, M. Reale, P. Gavazzano and G. Giuliano. 1999. Expression of lymphocyte subpopulations, cytokine serum levels, and blood and urinary trace elements in asymptomatic atopic men exposed to an urban environment. Int. Arch. Occup. Environ. Health. 72(1):26.
5. Hudson C.A., L. Cao, J. Kasten-Jolly, J.N. Kirkwood and D.A. Lawrence. 2003. Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms. J. Toxicol. Environ. Health A. 66:895.
6. Heo Y., W.T. Lee and D.A. Lawrence. 1998. Differential effect of lead and cAMP on development and activities of Th1-and Th2-lymphocytes. Toxicol. Sci. 43:172.
7. Governa M., M. Valentino and I. Visona. 1987. In vitro impairment of human granulocyte functions by lead. Arch. Toxicol. 59:421.
8. Queiroz M.L.S., M. Almeida, M.I. Gallão and N.F. Höehr. 1993. Defective neutrophil function in workers occupationally exposed to lead. Pharmacol. Toxicol. 72:73.
9. Basaran N. and U. Undeger. 2000. Effects of lead on immune parameters in occupationally exposed workers. Am. J. Ind. Med. 38:349.
10. Di Lorenzo L., A. Silvestroni, M.G. Martino, T. Gagliardi, M. Corfiati and L. Soleo. 2006. Evaluation of peripheral blood neutrophil leucocytes in lead-exposed workers. Int. Arch. Occup. Environ. Health 79:491.
11. Binder R., A. Kress, G. Kan, K. Herrmann and M. Kirschfink. 1999. Neutrophil priming by cytokines and vitamin D binding protein (Gc-globulin): impact on C5a-mediated chemotaxis, degranulation and respiratory burst. Mol. Immunol. 36:885.
12. Guo T.L., S.P. Mudzinski and D.A. Lawrence. 1996. The heavy metal lead modulates the expression of both TNF-alpha and TNF-alpha receptors in lipopolysaccharide-activated human peripheral blood mononuclear cells. J. Leukoc. Biol. 59:932.
13. Krocova Z., A. Macela, M. Kroca and L. Hernychova. 2000. The immunomodulatory effect(s) of lead and cadmium on the cells of immune system in vitro. Toxicol. In Vitro 14:33.
14. Santarelli L., M. Valentino, M. Bracci, V. Rapisarda, E. Mocchegiani, F. Cassano, L. Di Lorenzo and L. Soleo. 2003. Aumento del TNF-α in soggetti professionalmente esposti a Piombo. G. Ital. Med. Lav. Ergon. 25(S):90.
15. Yucesoy B., A. Turhan, M. Ure, T. Imir and A. Karakaya. 1997. Effects of occupational lead and cadmium exposure on some immunoregolatory cytokine levels in man. Toxicology 123:143.
16. Flohe S.B., J. Bruggemann, C. Herder, C. Goebel and H. Kolb. 2002. Enhanced proinflammatory response to endotoxin after priming of macrophages with lead ions. J. Leukoc. Biol. 71:417.
17. Cheng Y.J., B.C. Yang, W.C. Hsieh, B.M. Huang and M.Y. Liu. 2002. Enhancement of TNF-alpha expression does not trigger apoptosis upon exposure of glial cells to lead and lipopolysaccharide. Toxicology 178:183.
18. Milosevic N. and P. Maier. 2000. Lead stimulates intercellular signalling between hepatocytes and Kupffer cells. Eur. J. Pharmacol. 401:317.
19. Sallerfors B. 1994. Endogenous production and peripheral blood levels of granulocyte-macrophage (GM-) and granulocyte (G-) colony-stimulating factors. Leuk. Lymphoma 13:235.
20. Sasagawa S., K. Suzuki, T. Sakatani and T. Fujikura. 1985. Effects of nicotine on the functions of human polymorphonuclear leukocytes in vitro. J. Leukoc. Biol. 37:493.
21. Schwartz J. and S.T. Weiss. 1994. Cigarette smoking and peripheral blood leukocyte differentials. Ann. Epidemiol. 4:236.
22. Tappia P.S., K.L. Troughton, S.C. Langley-Evans and R.F. Grimble. 1995. Cigarette smoking influences cytokine production and antioxidant defences. Clin. Sci. (Lond) 88:485.
23. Tanabe N., K. Ohnishi, H. Fukui and R. Ohno. 1997. Effect of smoking on the serum concentration of erythropoietin and granulocyte-colony stimulating factor. Intern. Med. 36:680.
24. Abel G.A., J.T. Hays, P.A. Decker, G.A. Croghan, D.J. Kuter and N.A. Rigotti. 2005. Effects of biochemically confirmed smoking cessation on white blood cell count. Mayo Clin. Proc. 80:1022.
25. Apostoli P., A. Baj, P. Bavazzano, A. Ganzi, G. Neri, A. Ronchi, L. Soleo, L. Di Lorenzo, P. Spinelli, T. Vidente and C. Minoia. 2002. Blood lead reference values: the results of an Italian polycentric study. Sci. Total Environ. 287:1.
26. American Conference of Governmental Industrial Hygienists. 2003. Threshold Limit Values and Biological Exposure Indices. ACGIH, Cincinnati, OH.
27. Cheng Y.J., M.Y. Liu, T.P. Wu and B.C. Yang. 2004. Regulation of tumor necrosis factor-alpha in glioma cells by lead and lipopolysaccharide: involvement of common signaling pathway. Toxicol. Lett. 152:127.
28. van der Poll T., SJ. van Deventer, C.E. Hack, G.J. Wolbink, L.A. Aarden, H.R. Buller and J.W. ten Cate. 1992. Effects on leukocytes after injection of tumor necrosis factor into healthy humans. Blood 79:693.
29. van der Vaart H., D.S. Postma, W. Timens and N.H. ten Hacken. 2004. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 59:713.
30. Schulz S., U. Schagdarsurengin, T. Suss, U. Muller-Werdan, K. Werdan and C. Glaser. 2004. Relation between the tumor necrosis factor-alpha (TNF-alpha) gene and protein expression, and clinical, biochemical, and genetic markers: age, body mass index and uric acid are independent predictors for an elevated TNF-alpha plasma level in a complex risk model. Eur. Cytokine Netw. 15:105.
31. Dalhoff K., F. Hansen, D. Dromann, B. Schaaf, S.P. Aries and J. Braun. 1998. Inhibition of neutrophil apoptosis and modulation of the inflammatory response by granulocyte colony-stimulating factor in healthy and ethanol-treated human volunteers. J. Infect. Dis. 178:891.
32. Wiltschke C., M. Krainer, M. Nanut, A. Wagner, W. Linkesch and C.C. Zielinski. 1995. In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activity. J. Interferon Cytokine Res. 15:249.
33. Yong K.L. 1996. Granulocyte colony-stimulating factor (G-CSF) increases neutrophil migration across vascular endothelium independent of an effect on adhesion: comparison with granulocyte-macrophage colony-stimulating factor (GM-CSF). Br. J. Haematol. 94:40.
34. Roilides E., T.J. Walsh, P.A. Pizzo and M. Rubin. 1991. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J. Infect. Dis. 163:579.
35. Hartung T., S. von Aulock and A. Wendel. 1998. Role of granulocyte colony-stimulating factor in infection and inflammation. Med. Microbiol. Immunol. (Berl) 187:61.
36. Furman W.L., W. Lumm, B. Arnold, C.B. Pratt and J.N. Ihle. 1992. Recombinant human TNF-alpha stimulates the secretion of granulocyte colony-stimulating factor in vivo. Leukemia 6:319.
37. Sullivan G.W., A.K. Gelrud, H.T. Carper and G.L. Mandell. 1996. Interaction of tumor necrosis factor-alpha and granulocyte colony-stimulating factor on neutrophil apoptosis, receptor expression, and bactericidal function. Proc. Assoc. Am. Physicians 108:455.
38. Pollmacher T., C. Korth, J. Mullington, W. Schreiber, J. Sauer, H. Vedder, C. Galanos and F. Holsboer. 1996. Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood 87:900.
39. Xu S., M. Hoglund, L. Hakansson and P. Venge. 2000. Granulocyte colony-stimulating factor (G-CSF) induces the production of cytokines in vivo. Br. J. Haematol. 108:848.
40. Hakansson L., M. Hoglund, U.B. Jonsson, I. Torsteinsdottir, X. Xu and P. Venge. 1997. Effects of in vivo administration of G-CSF on neutrophil and eosinophil adhesion. Br. J. Haematol. 98:603.